Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13606188 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL13606190 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL128294 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL13606187 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL15105416 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL7646991 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL9998889 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL13606194 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL15105362 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL11510150 | 1.00 | SIGMAR1 (0.59) | SIGMAR1MAOAMAOBMAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1558948-A1 | SILOXANE OPTICAL WAVEGUIDES | Polyset Company, Inc. (US) | 2005-08-03 | — | — | EP | claimed |
| US-6832036-B2 | Siloxane optical waveguides | POLYSET COMPANY, INC. | 2004-12-14 | — | — | US | claimed |
| US-20040076391-A1 | Siloxane optical waveguides | POLYSET CHEMICAL COMPANY INC. (US) | 2004-04-22 | — | — | US | claimed |
| WO-2004034104-A1 | SILOXANE OPTICAL WAVEGUIDES | POLYSET COMPANY INC. (US) | 2004-04-22 | — | — | WO | claimed |
| US-20240116075-A1 | SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-04-11 | — | — | US | disclosed |
| CN-113149883-B | Process for preparing pyrrole compounds | 武田药品工业株式会社 | 2024-04-02 | — | — | CN | disclosed |
| EP-4287240-A1 | SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER | Central Glass Company, Limited (JP) | 2023-12-06 | — | — | EP | disclosed |
| US-20230322669-A1 | METHOD FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-4257577-A2 | METHOD FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2023-10-11 | — | — | EP | disclosed |
| CN-116438214-A | Sealing material for organic EL display element, cured product thereof, and organic EL display device | 三井化学株式会社 | 2023-07-14 | — | — | CN | disclosed |
| US-11649206-B2 | Method for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-16 | — | — | US | disclosed |
| US-20230143246-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| EP-0214823-A2 | Alkylamide derivatives with H2-receptor antagonistic and cytoprotective action | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1987-03-18 | — | — | EP | disclosed |
| US-4373073-A | Process for the preparation of glycidyl ethers of monohydric or polyhydric phenols, the glycidyl ethers and use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-08 | — | — | US | disclosed |
| US-4237290-A | ODORANTS, FLAVORINGS; REACTION OF A SULFONIUM SALT AND A MERCAPTAN | GIVAUDAN CORPORATION (US) | 1980-12-02 | — | — | US | disclosed |
| US-4188488-A | ALKYLIMIDAZOLYL SUBSTITUENTS | GIVAUDAN CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4180672-A | 2-Organothio-2-cyclopentenones, organothio-cyclopentanes derived therefrom | TEIJIN LIMITED (JP) | 1979-12-25 | — | — | US | disclosed |
| US-4170594-A | Oxazolyl-alkyl-disulphides as flavorants | GIVAUDAN CORPORATION (US) | 1979-10-09 | — | — | US | disclosed |
| US-4130562-A | Odorant or flavoring thiazolyl disulphides | GIVAUDAN CORPORATION (US) | 1978-12-19 | — | — | US | disclosed |
| US-3931058-A | POLYGLYCIDYL COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND USE | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143246-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | OTC, SLC38A7, SRI | SIGMAR1 248/4885MAOA 4/4885MAOB 8/4885 |
| US-20230322669-A1 | METHOD FOR PRODUCING PYRROLE COMPOUND | HPD, PPOX, CBR3 | SIGMAR1 3736/4885MAOA 231/4885MAOB 234/4885 |
| US-11649206-B2 | Method for producing pyrrole compound | HPD, PPOX, CBR3 | SIGMAR1 3736/4885MAOA 231/4885MAOB 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.